This site includes the webcasts from the 41st Union World Conference on Lung Health in Berlin, Germany (2010) and the 42nd Union World Conference on Lung Health in Lille, France (2011).
Log In
e-Mail address:
Password:
Forgot password?
Sign up now!
Information
Nutzungsbedingungen
Impressum
Browse
Type in a keyword to specify your content
Browse
Hide Filter Settings
Event
All Events
Lille 2011 (258)
Berlin 2010 (282)
Group
All Groups
Featured oral abstract (38)
Oral Abstracts (59)
Plenary sessions (21)
Symposia (410)
Workshops (12)
Session
All Sessions
01. eHealth for tuberculosis: integrating information and communications technology into tuberculosis care (2)
01. Key observations on TB care in high-burden countries (6)
01. Perspectives on global and national advocacy to reach Stop TB targets (3)
01. Research in tuberculosis diagnosis (4)
01. Robert Koch Lecture: Diagnosis of TB: from Robert Koch to 2010 (2)
02. Beyond numbers: the value of qualitative research for TB programme policy and practice (4)
02. Financing health systems to improve TB and HIV outcomes and to strengthen chronic care (2)
02. Progress in HIV and TB programmes linkages (6)
02. Role of partnerships in addressing TB control in prisons (4)
02. The spectrum of TB management issue (7)
03. Advances in MDR-TB treatment: findings from recent observational studies and clinical trials (5)
03. Clinical and epidemiological research in tuberculosis (5)
03. Financing health systems to improve tuberculosis and HIV outcomes, and strengthen chronic care (12)
03. Innovative partnerships for TB/HIV care of marginalised populations (6)
03. Scaling up Operational Research and using it to strengthen TB and HIV care in resource-poor countries (2)
03. Vaccines, drugs and diagnostics: potential new tools (4)
04. Biomarkers for lung diseases (3)
04. Biomarkers for tuberculosis in relation to the spectrum of HIV prevalence (3)
04. Improving the quality of coverage of collaborative TB-HIV activities (7)
04. TB-HIV clinical and epidemiological research and care (5)
05. Alcohol and drug use disorders, tuberculosis and HIV: research to programme solutions / interventions (3)
05. Decentralisation and scale-up of ART through TB clinics and other models of TB/HIV integration (4)
05. New tools and approaches (6)
05. TB programme implementation: grass roots and tree tops (7)
06. Clinical research and programme implementation in childhood TB (5)
06. Experiences in MDR-TB management: an around the world view (5)
06. Family-based approach and the fourth 'I': integrating maternal and child TB/HIV management (5)
06. Partnering initiatives to \'Stop TB\' at country level: how a partnering approach can help scale up care (4)
07. Epidemiology and clinical research in MDR-TB (6)
07. Epidemiology of drug-resistant TB: insights from partnerships (1)
07. Expanding TB programmes: issues in scaling up (7)
07. Human rights and ethical standards to strengthen TB care and control (4)
08. Bridging the gap between public health and clinical care: improved approaches to non-communicable diseases (5)
08. Implementing the Three I's (6)
08. Integration of comprehensive smokefree policies into health-care facilities (3)
09. NAP and NTP: establishing partnerships to accelerate innovation for TB/HIV collaborative activities (3)
09. Partnerships to develop alternative livelihood and crop diversification for tobacco control (4)
09. TB-HIV: epidemiology and response (4)
10. Childhood tuberculosis (7)
10. Innovations in research: diagnosis, treatment and infection control for MDR-TB (2)
10. TB REACH: Innovations and partnerships for early and increased TB case finding amongst the poor and vulnerable (5)
11. Controversies in HIV (3)
11. Public education for improved health: lessons for tobacco control (4)
12. Towards universal access: scaling-up access to TB/HIV diagnosis and treatment for marginalised populations (3)
13. Global laboratory initiative (3)
13. International Standards for Tuberculosis Care (ISTC): five years in the field (4)
14. Addressing human capacity development requirements for sustainable improvements in control and treatment of TB (5)
14. Partnerships to accelerate TB vaccine development (2)
15. Meeting the needs of the most neglected patients: the rising caseload of paediatric drug-resistant TB (4)
15. Research challenges to improve case management and reduce mortality in child pneumonia (4)
16. One health approach: coordinating diagnosis, surveillance, and education Programmes in zoonotic tuberculosis (3)
16. Tuberculosis in Indigenous peoples (2)
17. Management of asthma in low- and middle-income countries and the Asthma Drug Facility (3)
17. Zoonotic TB: public health and socioeconomic challenges: part 2 (4)
18. Fixed-dose combinations: past introduction and future innovation (4)
18. Smokefree healthcare as an entry point for scaling up tobacco control in high-burden countries (4)
19. Scaling-up interventions for child lung health (3)
19. Tuberculosis infection control (7)
20. Financing national MDR-TB scale-up programmes (4)
20. Microbial, environmental and host factors in the propagation of drug-resistant tuberculosis (6)
21. HIV controversies (4)
21. Tackling HIV and TB through partnerships (1)
22. Innovative advocacy, communication and social mobilisation to address TB and TB/HIV challenges (8)
22. Use of new molecular techniques for tracking transmission of M. tuberculosis and detecting drug resistance (2)
23. COPD in low- and middle-income countries (LMICs) (3)
23. Increasing access to quality, patient-centred care through partnerships (3)
24. External agencies and funders: are they really partners in international TB control and development? (4)
24. Translating assessments into training and education interventions for TB and HIV programmes (6)
25. Forging new alliances for a rights-based approach to TB prevention, care and control (1)
26. Optimal timing of antiretroviral initiation when TB is diagnosed: is there a need for new recommendations? (3)
26. Pilot projects to address TB burden in indigenous communities (5)
27. Tobacco control from policy to implementation (4)
27. TREAT TB: innovations in research (5)
28. Combating HIV/TB among vulnerable populations in Eastern Europe (3)
28. Global financing of TB control: improving performance and accelerating scale-up (1)
29. Quality laboratory management: the solution to providing reliable laboratory services (5)
29. Tuberculosis in health care workers: the response (5)
30. Fluoroquinolones: friend or foe? (4)
30. The corporate sector: key partners in the fight against TB and HIV (2)
31. A partnership approach to introducing new laboratory tools for TB diagnosis (4)
31. Getting the air clean: indoor air pollution and lung health (4)
32. Critical issues in TB clinical trials (6)
32. Enhancing partnerships in the fight against TB through training and education initiatives (4)
33. Gender and secondhand smoke (4)
33. Market-based approaches in TB treatment scale-up: lessons learnt, remaining issues and future opportunities (6)
34. Developing a global guideline for nutritional support to improve the health status of TB patients (4)
34. Late-breaker session (5)
35. Implementing smokefree legislation through partnerships: case studies of scaling up in developing countries (4)
35. Innovative approaches to scale up MDR-TB treatment globally (5)
36. Clinical research in child TB: an update and future challenges (3)
36. Tuberculosis, tobacco, HIV, COPD and other lung health issues: scaling up partnerships to drive research into policy and practice (4)
37. Improving integrated HIV care and treatment services for patients diagnosed with HIV in TB clinics (5)
37. Laboratory accreditation: essential for quality, but how to get there? (3)
38. Strategies to expand and improve active TB case finding (5)
38. M. tuberculosis strain diversity in high-burden countries (4)
39. Progress towards TB elimination in the EU and beyond: shortcomings and possible solutions in TB control (4)
39. Taking TB control beyond the clinic: impact of household and community interventions in Southern Africa (1)
40. Beyond labs and pills for improved tuberculosis control: what role for TB programmes? (4)
40. Scaling up TB/HIV integration,TB prevention, and care for pregnant women and children in high-burden settings (3)
41. National TB prevalence surveys: global progress, results and lessons learnt (4)
41. New developments with rifamycins: rifapentine, rifabutin, and high-dose rifampin (6)
41st Union World Conference Inaugural Session (4)
42. Community engagement: strengthening the evidence base to support patient and community perspectives in TB drug research (6)
42. Is scientific evidence enough to change policy? (4)
43. Advancements in TB drug R&D (4)
43. Inhalation approaches to tuberculosis and other lung infections (2)
44. Smoking cessation and smokefree environments for tuberculosis patients: lessons learnt from the field (4)
44.The Union/CDC Late-breaker session on tuberculosis (5)
45. Advances in intensified TB case finding and TB preventive therapy for people with HIV and application to programme practice (6)
45. From survey to action: COPD in low- and middle-income countries (5)
46. Clinical trials of new drugs and regimens for MDR- and XDR-TB (4)
46. Step-wise implementation of new diagnostic tools in high-burden countries and strategies for assessing their impact (4)
47. Expanding antiretroviral treatment (ART) uptake in HIV/TB (3)
47. Patients as partners (5)
48. Addressing TB and TB/HIV through innovations in TB vaccine development, population studies and clinical trials (3)
48. Implementing ICF and IPT: from policy to practice (2)
49. Health system response for human resources: ensuring TB workforce is present, competent, supervised and supported (6)
49. Partnership experiences with addressing the challenges of scaling-up new laboratory diagnostics (5)
50. Lessons from TB prevalence surveys into practice: experiences in Asia (7)
50. NTP/NAP: the impact of new diagnostic tools on access to TB/HIV services (3)
51. Innovative solutions to increase equitable access and quality of TB/HIV care in remote and isolated areas (6)
51. Scaling up public-private mix approaches for TB care and control (5)
52. Partnering beyond the formal health sector to promote access for hard-to-reach populations (3)
52. Tobacco and lung health: evidence for increased risk of TB, pneumonia, and asthma in children and adults (4)
53. Regional lessons on partnerships for scale-up of IPT and contact investigation in children (4)
54. Preventing tobacco industry interference in lung health by moving beyond monitoring to implementing policy solutions (4)
Inaugural Session (4)
Plenary session (1)
RUS - 01. Robert Koch Lecture: Diagnosis of TB: from Robert Koch to 2010 (1)
RUS - 02. Financing health systems to improve TB and HIV outcomes and to strengthen chronic care (1)
RUS - 03. Scaling up Operational Research and using it to strengthen TB and HIV care in resource-poor countries (1)
RUS - 41st Union World Conference Inaugural Session (3)
← Previous
1
2
3
4
5
6
7
8
9
…
44
45
Next →
Title:
42nd Union World Conference on Lung Health
Session:
Inaugural Session
Speaker:
Squire, S Bertel
Congress:
Lille 2011
Title:
42nd Union World Conference on Lung Health
Session:
Inaugural Session
Speaker:
Ceremony, Award
Congress:
Lille 2011
Title:
42nd Union World Conference on Lung Health
Session:
Inaugural Session
Speaker:
Ceremony, Inaugural
Congress:
Lille 2011
Title:
How the private sector can contribute to the scale-up of health services
Session:
Inaugural Session
Speaker:
Vestergaard Frandsen, Mikkel
Congress:
Lille 2011
Title:
Potential markers for a point of care test for tuberculosis disease
Session:
04. Biomarkers for lung diseases
Speaker:
McNerney, Ruth
Congress:
Lille 2011
Title:
Breath biomarkers for asthma
Session:
04. Biomarkers for lung diseases
Speaker:
Sterk, Peter
Congress:
Lille 2011
Title:
Biomarkers in sputum, serum and breath of tuberculous patients
Session:
04. Biomarkers for lung diseases
Speaker:
Kolk, Arend
Congress:
Lille 2011
Title:
At the crossroads of life and livelihoods: health and socio-economic concerns of bidi workers and tendu leaf pluckers in India
Session:
09. Partnerships to develop alternative livelihood and crop diversification for tobacco control
Speaker:
Mukhopadhyay, Bhavna
Congress:
Lille 2011
Title:
Alternative livelihood for bidi workers in southern districts of Tamil Nadu: best practices
Session:
09. Partnerships to develop alternative livelihood and crop diversification for tobacco control
Speaker:
Vidhubala, Elangovan
Congress:
Lille 2011
Title:
Exploring alternative livelihoods for farmers and alternatives to tobacco farming in Kenya
Session:
09. Partnerships to develop alternative livelihood and crop diversification for tobacco control
Speaker:
Otanez, Martin
Congress:
Lille 2011
Title:
Trends in tobacco farming: a case study from Tamil Nadu
Session:
09. Partnerships to develop alternative livelihood and crop diversification for tobacco control
Speaker:
Alexander, Cyril
Congress:
Lille 2011
Title:
Management of HIV and TB in post-earthquake Haiti: challenges and opportunities
Session:
03. Innovative partnerships for TB/HIV care of marginalised populations
Speaker:
Furin, Jennifer
Congress:
Lille 2011
← Previous
1
2
3
4
5
6
7
8
9
…
44
45
Next →